NUVEMZI Trademark

Trademark Overview

On Wednesday, August 14, 2019, a trademark application was filed for NUVEMZI with the United States Patent and Trademark Office. The USPTO has given the NUVEMZI trademark a serial number of 88578889. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Ovid Therapeutics Inc.. The NUVEMZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
nuvemzi

General Information

Serial Number88578889
Word MarkNUVEMZI
Filing DateWednesday, August 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
Translation of Words in MarkThe wording "NUVEMZI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOvid Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameOvid Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU EXTENSION 5 GRANTED
Tuesday, June 6, 2023SOU EXTENSION 5 FILED
Monday, June 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2022SOU EXTENSION 4 GRANTED
Wednesday, November 30, 2022SOU EXTENSION 4 FILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 8, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 8, 2022SOU EXTENSION 3 FILED
Wednesday, June 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, December 7, 2021SOU EXTENSION 2 FILED
Tuesday, December 7, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021SOU EXTENSION 1 GRANTED
Wednesday, June 2, 2021SOU EXTENSION 1 FILED
Wednesday, June 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 23, 2020TTAB RELEASE CASE TO TRADEMARKS
Friday, October 23, 2020OPPOSITION TERMINATED NO. 999999
Friday, October 23, 2020OPPOSITION DISMISSED NO. 999999
Wednesday, March 11, 2020OPPOSITION INSTITUTED NO. 999999
Wednesday, March 11, 2020OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 13, 2020EXAMINER'S AMENDMENT ENTERED
Monday, January 13, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 13, 2020EXAMINERS AMENDMENT E-MAILED
Monday, January 13, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, January 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2020ASSIGNED TO LIE
Thursday, December 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 17, 2019NEW APPLICATION ENTERED

Related Keywords

nuvemzi disorders neurological treatment pharmaceutical preparations developmental